Global  

State attorneys general: Use federal law to lower cost, increase supply of COVID-19 drug remdesivir

USATODAY.com Tuesday, 4 August 2020
California, Louisiana and other attorneys general say Gilead Sciences' antiviral should be licensed to others to ease potential shortages, lower price
0
shares
ShareTweetSavePostSend
 

💡 One News Page Knowledge: Other News Mentions

Louisiana Louisiana State in the southern United States

Guess Who This Striped Sweetie Turned Into!

Before this posin' pip-squeak was building an entire empire from his success, he was just another sweetie wearing stripes while growing up in New Orleans,..
TMZ.com

Man on parole after 23 years in jail for stealing hedge clippers

A man has been released from prison after more than 20 years behind bars for stealing a pair of hedge clippers.Fair Wayne Bryant, now 63, of Louisiana in the US,..
New Zealand Herald

Man Sentenced to Life Over Theft of Hedge Clippers Is Granted Parole

Before 2017, a person in Louisiana could be sentenced to life in prison after receiving a fourth nonviolent conviction under the state’s habitual offender law.
NYTimes.com

Guess Who This Happy Kid Turned Into!

Before this smirking sweetheart was making the best music around, he was just another happy kid growing up in New Orleans, Louisiana. This cutie with a bowl cut..
TMZ.com

Hurricane Delta wreaks havoc along Louisiana coastline weeks after Hurricane Laura

Coastal Louisiana was hit by yet another hurricane on Friday, weeks after Hurricane Laura battered the same area. David Begnaud reports from Lake Charles, where..
CBS News

California California State in the western United States

In California: Disneyland won't be reopening soon, ballot box set on fire in L.A. suburb

Plus: The state attorney general sues the GOP over its ballot drop boxes. Counties push back against state reopening guidelines. Greenhouse gas emissions..
USATODAY.com

Disneyland, Other California Theme Parks, Get Rules for Reopening

Large parks must be in the state’s “yellow” tier for economic recovery, with the virus largely contained, which could be a long wait.
NYTimes.com

50 Cent doubles down on Trump endorsement: ‘Don’t want to be 20 Cent’

50 Cent says he’s voting for his financial interests 50 Cent has made it very clear he is not interested in Joe Biden’s plan for America. The rapper went..
WorldNews

California releases new guidelines for theme park reopenings

Theme parks like Disneyland and Universal Studios Hollywood will have to wait until their counties reach the least restrictive "yellow" tier, according to the..
CBS News

VidCon is planning to return in summer 2021, and will allow people to attend digitally

VidCon, an annual convention focused on digital creators, is tentatively planning to return to Anaheim, California next summer if conditions allow, but..
The Verge

Gilead Sciences American pharmaceutical company

Covid: Remdesivir 'has little or no effect' on survival, says WHO

Drug manufacturer Gilead has questioned the findings, from a clinical study by the WHO.
BBC News

You Might Like


Related videos from verified sources

Trump Wants to Have Sheriffs, Police, Attorneys General at Polls for Election [Video]

Trump Wants to Have Sheriffs, Police, Attorneys General at Polls for Election

Law enforcement and attorneys general are some of the people that President Trump said he wants to send to poll locations for the upcoming election. Veuer’s Justin Kircher has the story.

Credit: Veuer     Duration: 01:06Published

Related news from verified sources

Under pressure to boost production of Covid-19 drug remdesivir, Gilead inks pact with Pfizer

Gilead Sciences Inc. lashed out earlier this week at state attorneys general critical of the drug maker's production of the Covid-19 drug remdesivir. On Friday,...
bizjournals Also reported by •RTTNewsHinduMotley Fool

Remdesivir Disappoints in COVID-19 Study

A new study is raising fresh questions about the efficacy of Gilead Sciences Inc's anti-viral medication remdesivir in COVID-19 patients. A randomized,...
Newsmax Also reported by •HindubizjournalsNYTimes.comNPRazcentral.comnewKerala.com

Biotech Firm Says It'll Make Enough Remdesivir to Meet Global Demand By October

Biotech firm Gilead Sciences said Thursday it'll be able to make enough of its antiviral remdesivir by October to meet global demand to treat COVID-19...
Newsmax Also reported by •NPRazcentral.comSeekingAlpha

Tweets about this